RNAC Annual Accounts Payable
$3.15 M
+$2.83 M+896.84%
31 December 2023
Summary:
As of January 23, 2025, RNAC annual accounts payable is $3.15 million, with the most recent change of +$2.83 million (+896.84%) on December 31, 2023. During the last 3 years, it has risen by +$2.71 million (+611.06%). RNAC annual accounts payable is now -18.86% below its all-time high of $3.88 million, reached on December 1, 2016.RNAC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Quarterly Accounts Payable
$517.00 K
-$2.35 M-81.94%
01 September 2024
Summary:
As of January 23, 2025, RNAC quarterly accounts payable is $517.00 thousand, with the most recent change of -$2.35 million (-81.94%) on September 1, 2024. Over the past year, it has dropped by -$2.00 million (-79.46%). RNAC quarterly accounts payable is now -87.92% below its all-time high of $4.28 million, reached on June 1, 2017.RNAC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +896.8% | -79.5% |
| 3 y3 years | +611.1% | +63.6% |
| 5 y5 years | +186.4% | +63.6% |
RNAC Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1306.3% | -83.6% | +141.6% |
| 5 y | 5-year | at high | +1306.3% | -83.6% | +235.7% |
| alltime | all time | -18.9% | +1306.3% | -87.9% | +235.7% |
Cartesian Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $517.00 K(-81.9%) |
| June 2024 | - | $2.86 M(+13.7%) |
| Mar 2024 | - | $2.52 M(-20.1%) |
| Dec 2023 | $3.15 M(+896.8%) | $3.15 M(+740.0%) |
| Sept 2023 | - | $375.00 K(+40.4%) |
| June 2023 | - | $267.00 K(-74.9%) |
| Mar 2023 | - | $1.06 M(+236.4%) |
| Dec 2022 | $316.00 K(+41.1%) | - |
| Dec 2022 | - | $316.00 K(+47.7%) |
| Sept 2022 | - | $214.00 K(-69.1%) |
| June 2022 | - | $693.00 K(+162.5%) |
| Mar 2022 | - | $264.00 K(+17.9%) |
| Dec 2021 | $224.00 K(-49.4%) | $224.00 K(-85.9%) |
| Sept 2021 | - | $1.59 M(+934.4%) |
| June 2021 | - | $154.00 K(-74.1%) |
| Mar 2021 | - | $594.00 K(+34.1%) |
| Dec 2020 | $443.00 K | $443.00 K(-5.9%) |
| Sept 2020 | - | $471.00 K(-62.1%) |
| June 2020 | - | $1.24 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $1.33 M(+166.0%) |
| Dec 2019 | $500.00 K(-54.5%) | $500.00 K(-66.2%) |
| Sept 2019 | - | $1.48 M(-40.0%) |
| June 2019 | - | $2.46 M(+255.4%) |
| Mar 2019 | - | $693.00 K(-37.0%) |
| Dec 2018 | $1.10 M(-31.5%) | $1.10 M(-12.1%) |
| Sept 2018 | - | $1.25 M(-30.0%) |
| June 2018 | - | $1.79 M(0.0%) |
| Mar 2018 | - | $1.79 M(+11.4%) |
| Dec 2017 | $1.61 M(-58.6%) | $1.61 M(+5.7%) |
| Sept 2017 | - | $1.52 M(-64.5%) |
| June 2017 | - | $4.28 M(+225.0%) |
| Mar 2017 | - | $1.32 M(-66.1%) |
| Dec 2016 | $3.88 M(+78.2%) | $3.88 M(+273.3%) |
| Sept 2016 | - | $1.04 M(+10.3%) |
| June 2016 | - | $943.00 K(+19.7%) |
| Mar 2016 | - | $788.00 K(-63.8%) |
| Dec 2015 | $2.18 M(+520.8%) | $2.18 M |
| Dec 2014 | $351.00 K | - |
FAQ
- What is Cartesian Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual accounts payable year-on-year change?
- What is Cartesian Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly accounts payable year-on-year change?
What is Cartesian Therapeutics annual accounts payable?
The current annual accounts payable of RNAC is $3.15 M
What is the all time high annual accounts payable for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual accounts payable is $3.88 M
What is Cartesian Therapeutics annual accounts payable year-on-year change?
Over the past year, RNAC annual accounts payable has changed by +$2.83 M (+896.84%)
What is Cartesian Therapeutics quarterly accounts payable?
The current quarterly accounts payable of RNAC is $517.00 K
What is the all time high quarterly accounts payable for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly accounts payable is $4.28 M
What is Cartesian Therapeutics quarterly accounts payable year-on-year change?
Over the past year, RNAC quarterly accounts payable has changed by -$2.00 M (-79.46%)